Kameran Lashkari is an Ophthalmology physician affiliated with University of Massachusetts Dartmouth. OpenAlex indexes 108 publications with 2,325 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
60%Vascular Endothelial Growth Factor Inhibitor60%Aflibercept87%Bevacizumab13%Part B, office-administered≥184 patientsSensory organs
30.8%Vascular Endothelial Growth Factor Inhibitor16.9%Ranibizumab100%Part B, office-administered≥29 patientsCorticosteroid6%Dexamethasone58%Prednisolone Acetate42%Part D + Part B≥68 patients+ 8 more classes in this area
Musculoskeletal
4.4%Cyclooxygenase Inhibitor3.8%Ketorolac Tromethamine100%Part D≥63 patientsNonsteroidal Anti-inflammatory Drug0.5%Diclofenac Sodium100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”